Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
Abstract Background Insulin is highly recommended for diabetes management in persons with liver cirrhosis. However, few studies have evaluated its long-term effects in these persons. We conducted this study to compare the risks of mortality, liver-related complications, and cardiovascular events in...
Main Authors: | Fu-Shun Yen, Jung-Nien Lai, James Cheng-Chung Wei, Lu-Ting Chiu, Chih-Cheng Hsu, Ming-Chih Hou, Chii-Min Hwu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01773-x |
Similar Items
-
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
by: Fu-Shun Yen, et al.
Published: (2022-12-01) -
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
by: Fu-Shun Yen, et al.
Published: (2023-01-01) -
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
by: Fu-Shun Yen, et al.
Published: (2024-01-01) -
Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
by: Chih-Lin Lin, et al.
Published: (2020-10-01) -
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
by: Fu-Shun Yen, et al.
Published: (2022-02-01)